Skip to main content Accessibility help
×
Home

Three Generations of Bile Acid Sequestrants

  • W. Harry Mandeville (a1), William Braunlin (a1), Pradeep Dhal (a1), Amy Guo (a1), Chad Huval (a1), Karen Miller (a1), John Petersen (a1), Steven Polomoscanik (a1), David Rosenbaum (a1), Robert Sacchiero (a1), James Ward (a1) and S. Randall Holmes-Farley (a1)...

Abstract

Cholestyramine, the first bile acid sequestrant to be marketed, has been in use for over 20 years. Despite its low potency, requiring 16-24 g of polymer to achieve 20% LDL cholesterol reduction in hypercholesterolemic individuals, only one other sequestrant, colestipol, has come to market in the ensuing period. GelTex Pharmaceuticals has been involved for over six years in the discovery and development of new, more potent polymeric sequestrants. Two binding mechanisms are presented — one that operates via an aggregate binding structure and one that is effective via a defined site binding structure. These two binding mechanisms are compared and contrasted through bile acid binding isotherms. The best of these new sequestrants bind bile acids through a combination of hydrophobicity and ion exchange. Optimization and balancing of each of these interactions led us to more potent materials. The first of these, colesevelam hydrochloride is expected to be three to four times more potent than cholestyramine. A third generation product is still in research at GelTex. With another twofold increase in potency possible, single tablet therapy may become a reality.

Copyright

References

Hide All
1. Bergen, S. S., Van Itallie, T. B., Tennent, D. M. and Sebrell, W. H., Proc. Soc. Exp. Biol., 102, pp. 676679 (1959).
2. Stedronsky, E. R., Biochim. et Biophys. Acta, 1210, pp. 255287 (1994) and references therein.
3. Newman, T. B. and Hully, S. B., J. Am. Med. Assoc., 275, pp. 5560 (1996).
4. Myant, N. B. and Mitropoulos, K. A., J. Lipid Res., 18, pp. 135153 (1977).
5. Dietschy, J. M. and Wilson, J. D., N. Engl. J. Med., 282, pp. 1128–38, 1179 (1970).
6. Miettinen, T. A., Adv. Lipid Res., 18, pp. 6597 (1981).
7. Ostrow, J. D. in Hepatic Transport and Bile Secretion: Physiology and Pathophysiology: Tavolini, N. and Berk, P. D., Eds., Raven Press, New York, 1993, pp. 673712 and references therein.
8. Buchwald, H., Moore, R. B., and Varco, R. L., Circulation, 49, pp. 137 (1974), Suppl. I.
9. Miettinen, T. A. and Lempinen, M., Eur. J. Clin. Invest., 7, pp. 509514 (1977).
10. Benson, G. M., Haynes, C., Blanchard, S. and Ellis, D., J. Pharm Sci., 82, pp. 8086 (1993).
11. Luner, P. E. and Amidon, G. L., J. Pharm. Sci., 82, pp. 311318 (1993).
12. Andersen, E., Scand. J. Gastroenterol., 14, pp. 657672 (1974).
13. Einarsson, K., Hellstrom, K. and , Kallner, Eur. J. Clin. Invest., 4, pp. 405410 (1974).
14. Garbutt, J. T. and Kenney, J. T., J. Clin. Invest., 57, pp. 27812789 (1972).
15. Thistle, J. L. and Schoenfield, L. J., J. Lab. Clin. Med., 74, pp. 10201021 (1969).
16. Wood, P. D., Shioda, R., Estrich, D. L. and Splitter, S. D., Metabolism, 21, pp. 107116 (1972).
17. Packard, C. J. and Sheperd, J., J. Lipid Res., 23, pp. 10811098 (1982).
18. Miettinen, T. A., Eur. J. Clin. Invest., 4, p. 365 (1974).
19. Miettinen, T. A. in Proc. Sixth Int. Congr. Pharmacol., Finnish Pharmacol. Soc., Helsinki, 1975, Vol. 4, pp. 149158.
20. Zhu, X. X., Brown, G. R. and St. Pierre, L. E., J. Pharm. Sci., 81, pp. 6569 (1992).
21. Hagerman, L. M., Cook, D. A. and Schneider, D. L., Proc. Soc. Exp. Biol. and Med., 199, pp. 248253 (1972).
22. Leonard, D., Clas, S.-D. and brown, G. R., React. Polym., 20, pp. 131140 (1993).
23. Luner, P. E. and Amidon, G. L., Pharm. Res., 9, pp. 670676 (1992).
24. Polli, J. E. and Amidon, G. L., J. Pharm.. Sci., 84, pp. 5561 (1995).
25. Hagerman, L. M., Julow, D. A. and Schneider, D. L., Proc. Soc. Exp. Biol. Med., 143, pp. 8992 (1973).
26. Goddard, E. D., J. Amer. Oil Chem. Soc., 71, pp. 115 (1994) and references therein.
27. Lindman, B. and Thalberg, K., in Interactions of Surfactants with Polymers and Proteins, edited by Goddard, E. D. and Ananthapadmanabhan, K. P., CRC Press, Boca Raton, 1993, pp. 203276.
28. Yim, C. T. and Brown, G. R., Langmuir, 10, pp. 41954202 (1994).
29. Mandeville, W. H., Holmes-Farley, S. R., Garigapati, V., Miller, K. L., Ward, J., Marchese, S., Ahearn, P. and Chen, X., poster presented at the Falk Conference, San Diego, CA, Sept. 29-30, (1994).
30. Wu, G., Brown, G. R., and St. Pierre, L. E., Langmuir, 12, pp. 466471 (1996).
31. Cohen, D. E., Kaler, E. W. and Carey, M. C., Hepatology, 18, pp. 15221531 (1993).
32. Anthony, O. and Zana, R., Langmuir, 12, pp. 19671975 (1996).
33. Anthony, O. and Zana, R., Langmuir, 12, pp. 35903597 (1996).

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed